Form 8-K - Current report:
SEC Accession No. 0001564590-21-037772
Filing Date
2021-07-23
Accepted
2021-07-23 18:36:45
Documents
13
Period of Report
2021-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-8k_20210719.htm   iXBRL 8-K 41334
2 EX-10.1 acet-ex101_8.htm EX-10.1 308059
  Complete submission text file 0001564590-21-037772.txt   529354

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acet-20210719.xsd EX-101.SCH 5779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20210719_lab.xml EX-101.LAB 20218
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20210719_pre.xml EX-101.PRE 12087
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-8k_20210719_htm.xml XML 3679
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211111896
SIC: 2834 Pharmaceutical Preparations